|
1
|
Bennett S and Thomas AJ: Depression and
dementia: Cause, consequence or coincidence? Maturitas. 79:184–190.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Korczyn AD and Halperin I: Depression and
dementia. J Neurol Sci. 283:139–142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu MY, Zhang LJ, Zhou YX and Wei WL:
5-Hydroxytryptamine changes under different pretreatments on rat
models of myocardial infarction and/or depression. Chin Med J
(Engl). 130:2219–2225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Teo CH, Soga T and Parhar IS: Brain
beta-catenin signalling during stress and depression. Neurosignals.
26:31–42. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martocchia A, Curto M, Scaccianoce S,
Comite F, Xenos D, Nasca C, Falaschi GM, Ferracuti S, Girardi P,
Nicoletti F, et al: Effects of escitalopram on serum BDNF levels in
elderly patients with depression: A preliminary report. Aging Clin
Exp Res. 26:461–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu X, Xu Y, Zhu B, Liu Q, Yao Q and Zhao
G: Resveratrol induces apoptosis in SGC-7901 gastric cancer cells.
Oncol Lett. 16:2949–2956. 2018.PubMed/NCBI
|
|
7
|
Li J, Xie C, Zhuang J, Li H, Yao Y, Shao C
and Wang H: Resveratrol attenuates inflammation in the rat heart
subjected to ischemia-reperfusion: Role of the TLR4/NF-κB signaling
pathway. Mol Med Rep. 11:1120–1126. 2015.PubMed/NCBI
|
|
8
|
Tan L, Wang W, He G, Kuick RD, Gossner G,
Kueck AS, Wahl H, Opipari AW and Liu JR: Resveratrol inhibits
ovarian tumor growth in an in vivo mouse model. Cancer.
122:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tresguerres IF, Tamimi F, Eimar H,
Barralet J, Torres J, Blanco L and Tresguerres JA: Resveratrol as
anti-aging therapy for age-related bone loss. Rejuvenation Res.
17:439–445. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Subramanian M, Goswami M, Chakraborty S
and Jawali N: Resveratrol induced inhibition of Escherichia
coli proceeds via membrane oxidation and independent of
diffusible reactive oxygen species generation. Redox Biol.
2:865–872. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miniati M, Callari A, Calugi S, Rucci P,
Savino M, Mauri M and Dell'Osso L: Interpersonal psychotherapy for
postpartum depression: A systematic review. Arch Women Ment Health.
17:257–268. 2014. View Article : Google Scholar
|
|
12
|
Segura-Aguilar J, Paris I, Muñoz P,
Ferrari E, Zecca L and Zucca FA: Protective and toxic roles of
dopamine in Parkinson's disease. J Neurochem. 129:898–915. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Fan Y, Xiao S, Peng S, Dong X, Zheng
X, Liu CC, Li H and Xiao Z: Decreased platelet 5-hydroxytryptamin
(5-HT) levels: A response to antidepressants. J Affect Disord.
187:84–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilkinson ST, Kiselycznyk C, Banasr M,
Webler RD, Haile C and Mathew SJ: Serum and plasma brain-derived
neurotrophic factor and response in a randomized controlled trial
of riluzole for treatment resistant depression. J Affect Disord.
241:514–518. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun Z, Liu S, Kharlamov EA, Miller ER and
Kelly KM: Hippocampal neuropeptide Y protein expression following
controlled cortical impact and posttraumatic epilepsy. Epilepsy
Behav. 87:188–194. 2018. View Article : Google Scholar : PubMed/NCBI
|
